1. Home
  2. BR vs NBIX Comparison

BR vs NBIX Comparison

Compare BR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadridge Financial Solutions Inc.

BR

Broadridge Financial Solutions Inc.

HOLD

Current Price

$180.85

Market Cap

18.7B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$145.53

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BR
NBIX
Founded
1962
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
15.5B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
BR
NBIX
Price
$180.85
$145.53
Analyst Decision
Buy
Strong Buy
Analyst Count
9
29
Target Price
★ $213.38
$206.22
AVG Volume (30 Days)
652.8K
★ 1.2M
Earning Date
11-03-2026
11-02-2026
Dividend Yield
★ 2.38%
N/A
EPS Growth
35.21
★ 41.95
EPS
★ 9.60
3.30
Revenue
★ $4,142,600,000.00
$161,626,000.00
Revenue This Year
$5.06
$36.49
Revenue Next Year
$4.94
$16.87
P/E Ratio
★ $19.02
$43.24
Revenue Growth
N/A
★ 977.51
52 Week Low
$133.83
$122.14
52 Week High
$233.10
$186.12

Technical Indicators

Market Signals
Indicator
BR
NBIX
Relative Strength Index (RSI) 65.73 54.60
Support Level $164.21 $125.18
Resistance Level $186.91 $146.92
Average True Range (ATR) 3.56 3.14
MACD 1.99 1.20
Stochastic Oscillator 82.46 96.43

Price Performance

Historical Comparison
BR
NBIX

About BR Broadridge Financial Solutions Inc.

Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: